Med: Infectious Diseases

I am an infectious diseases physician and epidemiologist    OUr lab is well know internationally in two major areas:  1.  The role of infections in chronic diseases and 2.  Physiologic changes in humans over time, specifically the decrease in human body temperature.  3. Novel surveillance projects, especially serosurveys done through the mail and  the use of wastewater to track infections.  Right now, projects that could integrate a post-doctoral fellow include:  In addition, my research group works on gun violence prevention.  

Dr. Parsonnet is an Infectious Diseases epidemiologist and clinician.  The Parsonnet lab works to understand how infectious agents influence the development of chronic diseases.  During the COVID crisis, the lab has also been actively involved in a wide range of investigations of this disease ranging from large seroepidemiologic studies to novel treatment trials to collaborative studies on COVID immunology.  Studies that could potentially take a fellow include:

Our basic research program focuses on understanding the roles of virus-host interactions in viral infection and disease pathogenesis via both molecular and systems virology/immunology single cell approaches. This program is combined with translational efforts to apply this knowledge for the development of broad-spectrum host-centered antiviral approaches to combat emerging viral infections, including dengue, encephalitic alphaviruses, SARS-CoV-2 and Ebola, and means to predict disease progression.

My lab is focused on understanding host-pathogen interactions with a particular focus on innate immune responses. We apply omics approaches to dissect these interactions, performing in vivo profiling and building in vitro systems to define host-pathogen interactions. We have a particular passion for understanding the mechanisms by which NK cells recognize and respond to pathogens. We currently have projects evaluating immunity to SARS-CoV-2, HIV, influenza, and tuberculosis. Department URL: https://medicine.stanford.edu/

Dr. Luby’s research group is engaged in several efforts to generate knowledge that will alter the way that bricks are manufactured across South Asia so that they generate less air pollution, less climate change and tens of thousands fewer deaths per year. This involves: 1) evaluating interventions to improve combustion efficiency within brick kilns and so simultaneously reduce coal costs for producers while generating less pollution 2) using remote sensing to specify the location of brick kilns and ultimately evaluate their emissions.

Singh lab - basic and translational science for parasitic amebic pathogens including gene expression, developmental control and identification of new drug regimens.

The primary research focus of the Relman Lab is the human indigenous microbiota (microbiome), and in particular, the nature and mechanisms of variation in patterns of microbial diversity within the human body as a function of time (microbial succession), space (biogeography within the host landscape), and in response to perturbation, e.g., antibiotics (community robustness and resilience). One of the goals of this work is to define the role of the human microbiome in health and disease.